Tus kws kho mob
QP28-23 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 12, 2023
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 951 - 960 ntawm 4179
Tus kws kho mob
QP29-23 Blue Cross Preferred Genetic Laboratory Program
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 12, 2023
Tus kws kho mob
QP30-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective May 1, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 12, 2023
Tus kws kho mob
QP31-23 Commercial Pharmacy Benefit Exclusion for Fluticasone-Salmeterol
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 12, 2023
Tus kws kho mob
QP32-23 Review and Update NPI Information
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 12, 2023
Tus kws kho mob
QP33-23 Provider Survey: Training & Development Focusing on Equity in Health Care
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 12, 2023
Tus kws kho mob
QP34-23 Update for New to Market Medical Drugs: Tofersen
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 12, 2023
Tus kws kho mob
QP35-23 Notice of Correction to Ambulance Mileage Reimbursement
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 12, 2023
Cov Txiaj Ntsig thiab Kev Duav Roos
BlueRide Parent or Guardian Ride Consent Form
Tus kws kho mob
P17-23 Inflation Reduction Act (IRA): Part B Rebatable Drugs and Part B Insulin Cap
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 03, 2023